Advertisement feature
See all supplementsPhIRDA: From imitator to innovator
In this Supplement
-
Determined to become a leader in science and technology innovation, China, the world’s second-largest pharmaceutical market, has put drug innovation high on its development agenda. Its launch of a national-level multi-billion dollar project has seen significant improvement in capabilities of basic drug research and clinical research, along with rising new drug discoveries. With a healthy environment for biomedical innovation, the Chinese pharmaceutical industry is transforming from an imitator to an innovator.
Free full access
